iobenguane I 131

RADIATION8 trials

Sponsors

New Approaches to Neuroblastoma Therapy Consortium, Memorial Sloan Kettering Cancer Center, University of California, San Francisco, German Society for Pediatric Oncology and Hematology GPOH gGmbH, Centre Oscar Lambret

Conditions

NeuroblastomaPheochromocytoma

Phase 1

N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma

CompletedNCT00005978

New Approaches to Neuroblastoma Therapy ConsortiumNeuroblastoma

Start: 2000-05-31Updated: 2010-10-15

N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation

CompletedNCT00083135

New Approaches to Neuroblastoma Therapy ConsortiumNeuroblastoma

Start: 2004-03-01Target: 18Updated: 2026-04-14

N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma

CompletedNCT00509353

New Approaches to Neuroblastoma Therapy ConsortiumNeuroblastoma

Start: 2007-01-01End: 2012-05-01Updated: 2026-04-14

Phase 2

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

RecruitingNCT00107289

Memorial Sloan Kettering Cancer CenterNeuroblastoma, Pheochromocytoma

Start: 2006-05-01End: 2027-05-01Target: 200Updated: 2026-05-29

131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma

CompletedNCT00293319

University of California, San FranciscoNeuroblastoma

Start: 2005-04-30End: 2006-03-31Updated: 2014-08-18

Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma

CompletedNCT00960739

Centre Oscar LambretNeuroblastoma

Start: 2008-11-30End: 2016-07-31Updated: 2016-08-08

Phase 3

Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma

German Society for Pediatric Oncology and Hematology GPOH gGmbHNeuroblastoma

Start: 2004-10-31Target: 642Updated: 2013-08-07

Unknown Phase

Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma

German Society for Pediatric Oncology and Hematology GPOH gGmbHNeuroblastoma

Start: 2007-01-31Target: 360Updated: 2015-07-16

Related Papers

Phase II study of <sup>131</sup>I‐metaiodobenzylguanidine with 5 days of topotecan for refractory or relapsed neuroblastoma: Results of the French study MIITOP

Pediatric Blood & Cancer2023-08-1311 citations

Treatment and outcome of Ganglioneuroma and Ganglioneuroblastoma intermixed

BMC Cancer2016-07-27127 citations

Feasibility of Administering High-Dose<sup>131</sup>I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined Rooms

Pediatric Blood & Cancer2016-01-1519 citations

Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.

2016-01-0713 citations